Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis
Circulation: Cardiovascular Quality and Outcomes · 2023-04 · 16 (4)
DOI: 10.1161/circoutcomes.122.009348 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Circulation: Cardiovascular Quality and Outcomes, 2023-04. Verfasst von Jamie Hartmann-Boyce und 12 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Primary Care Health Sciences (J.H.-B., A.T., A.R.B., A.B., R.B., F.D.R.H., S.A.J., P.A.), University of Oxford, United Kingdom. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Weight Reduction Programs. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Department of Health.
Abstract (Originalsprache)
Background
Behavioral weight management programs (BWMPs) enhance weight loss in the short term, but longer term cardiometabolic effects are uncertain as weight is commonly regained. We assessed the impact of weight regain after BWMPs on cardiovascular risk factors, diabetes, and cardiovascular disease.
Methods
Trial registries, 11 databases, and forward-citation searching (latest search, December 19) were used to identify articles published in English, from any geographical region. Randomized trials of BWMPs in adults with overweight/obesity reporting cardiometabolic outcomes at ≥12 months at and after program end were included. Differences between more intensive interventions and comparator groups were synthesized using mixed-effects, meta-regression, and time-to-event models to assess the impact of weight regain on cardiovascular disease incidence and risk.
Results
One hundred twenty-four trials reporting on ≥1 cardiometabolic outcomes with a median follow-up of 28 (range, 11–360) months after program end were included. Median baseline participant body mass index was 33 kg/m 2 ; median age was 51 years. Eight and 15 study arms (7889 and 4202 participants, respectively) examined the incidence of cardiovascular disease and type 2 diabetes, respectively, with imprecise evidence of a lower incidence for at least 5 years. Weight regain in BWMPs relative to comparators reduced these differences. One and 5 years after program end, total cholesterol/HDL (high-density lipoprotein) ratio was 1.5 points lower at both times (82 studies; 19 003 participants), systolic blood pressure was 1.5 mm mercury and 0.4 mm lower (84 studies; 30 836 participants), and HbA1c (%) 0.38 lower at both times (94 studies; 28 083 participants). Of the included studies, 22% were judged at high risk of bias; removing these did not meaningfully change results.
Conclusions
Despite weight regain, BWMPs reduce cardiometabolic risk factors with effects lasting at least 5 years after program end and dwindling with weight regain. Evidence that they reduce the incidence of cardiovascular disease or diabetes is less certain. Few studies followed participants for ≥5 years. Registration: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: CRD42018105744.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuffield Department of Primary Care Health Sciences (J.H.-B., A.T., A.R.B., A.B., R.B., F.D.R.H., S.A.J., P.A.), University of Oxford, United Kingdom.
- NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust, United Kingdom (J.L.O.).
- Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, United Kingdom (A.B.).
- Oxford University Hospitals NHS Foundation Trust, United Kingdom (A.D.).
- Royal Free London NHS Foundation Trust, United Kingdom (A.D.).
- United Nations World Food Programme, Cox's Bazar, Bangladesh, India (R.B.).
ORCID-Profile: Jamie Hartmann-Boyce, Annika Theodoulou, Jason L Oke, Ailsa R Butler, Anastasios Bastounis, Anna Dunnigan, Linda J Cobiac, Peter Scarborough, F D Richard Hobbs, Susan A Jebb, Paul Aveyard
Förderung
- British Heart Foundation
- Department of Health
Zitieren
APA
Hartmann-Boyce, J., Theodoulou, A., Oke, J. L., Butler, A. R., Bastounis, A., Dunnigan, A., Byadya, R., Cobiac, L. J., Scarborough, P., Hobbs, F. D. R., Sniehotta, F. F., Jebb, S. A., & Aveyard, P. (2023). Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomes, 16(4). https://doi.org/10.1161/circoutcomes.122.009348
Vancouver
Hartmann-Boyce J, Theodoulou A, Oke JL, Butler AR, Bastounis A, Dunnigan A, et al. Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis. Circulation: Cardiovascular Quality and Outcomes. 2023;16(4). doi:10.1161/circoutcomes.122.009348
BibTeX
@article{HartmannBoyce2023,
author = {Hartmann-Boyce, Jamie and Theodoulou, Annika and Oke, Jason L and Butler, Ailsa R and Bastounis, Anastasios and Dunnigan, Anna and Byadya, Rimu and Cobiac, Linda J and Scarborough, Peter and Hobbs, F D Richard and Sniehotta, Falko F and Jebb, Susan A and Aveyard, Paul},
title = {Long-Term Effect of Weight Regain Following Behavioral Weight Management Programs on Cardiometabolic Disease Incidence and Risk: Systematic Review and Meta-Analysis},
journal = {Circulation: Cardiovascular Quality and Outcomes},
year = {2023},
volume = {16},
number = {4},
doi = {10.1161/circoutcomes.122.009348}
}
EUVIMED